ArticleBrain pathology (Zurich, Switzerland)2024

MET fusions and splicing variants is a strong adverse prognostic factor in astrocytoma, isocitrate dehydrogenase mutant.

Lingyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.